BEAM THERAPEUTICS INC. - COMMON STOCK

Beam Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to its Board of Directors

08 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Upcoming Preclinical Data Presentations at the American Society of Hematology Annual Meeting

04 Nov 2021 09:40:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Jefferies Gene Therapy/Editing Summit

20 Oct 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Preclinical Data Highlighting Base Editing Approach to Correct a Glycogen Storage Disease Type Ia Disease-Causing Mutation

19 Oct 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Present Preclinical Data Highlighting Potential of CAR T Multiplex Base Editing Approach Targeting CD5 at 2021 SITC Annual Meeting

01 Oct 2021 08:43:59 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference

28 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Updated Preclinical Data Highlighting Optimized LNP Delivery Approaches for In Vivo Base Editing to the Liver and Other Tissues

23 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

08 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results

10 Aug 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference

03 Aug 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference

08 Jul 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference

25 May 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results

11 May 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Oral and Poster Presentations at 24th American Society of Gene and Cell Therapy Annual Meeting

27 Apr 2021 16:41:11 By Nasdaq GlobeNewswire

Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing

20 Apr 2021 10:12:36 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Business and Pipeline Progress and Reports Fourth Quarter and Full Year 2020 Financial Results

15 Mar 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Appoints Amy Simon, M.D., Chief Medical Officer

15 Mar 2021 06:15:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Barclays 2021 Global Healthcare Conference

04 Mar 2021 06:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Acquisition of Guide Therapeutics

23 Feb 2021 08:34:34 By Nasdaq GlobeNewswire

Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors

19 Jan 2021 06:30:00 By Nasdaq GlobeNewswire